Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides https://t.co/PJXE4qhyAj #medRxiv
Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Aug 2021 – May 2025Where it's discussed
-
X / Twitter7 posts
-
YouTube2 videos
AI synopsis
What people are saying
Overall, the discussions express strong interest and moderate engagement, with posts referencing the study’s focus on oral bacteria differences in obesity and depression, as well as implications for inflammation treatment. Words like 'different,' 'importance,' and hashtags like '#ScientificArticles' highlight both curiosity and recognition of its potential significance, but without deep dives into the methodology or broader implications.
Most discussions recognize the significance of the study, emphasizing the links between oral bacteria, depression, and obesity, reflecting broad agreement on its relevance.
The use of terms like 'new study,' 'novel insights,' and hashtags suggests high curiosity and engagement with the scientific findings.
Participants reference specific aspects such as inflammation and oral microbiome management, indicating moderate depth in their discussion, but mostly highlighting the importance rather than detailed critique.
The discussions suggest that this research could influence future approaches to managing depression and obesity through microbiome-related interventions, indicating potential impact.
Abstract in brief
- The study found that specific oral bacteria and their neuroactive metabolites are linked to depression, obesity, and their co-occurrence, with Gram-negative bacteria being more prevalent in people with both conditions and supporting an inflammation connection.
- Metabolomic analysis showed changes in signaling molecules, amino acids, and neuropeptides associated with these conditions, indicating that the microbiome may influence brain-related processes through neuroactive compounds.
- Integrating microbiome and metabolomics data suggests that oral microbes may produce neuroactive substances like dopamine, serotonin, and epinephrine precursors, highlighting a potential microbial-brain communication pathway involved in depression and obesity.]
Top posts
Most liked on X and BlueskyRT @BMC_series: Suzi Hong and co-authors have published in #BMCMicrobiol a study reporting novel insights into oral microbial-brain connect…
Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides https://t.co/2199I3wvII
Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides https://t.co/sTy7OaMLEx
A new study reports the bacterial mix of saliva differs in obese and depressed adults. https://t.co/0YW3nPSgvn Obesity and depression are driven by inflammation. Gum disease lifts inflammation by 20%. So managing the oral microbiome with Prevora becomes even more important. https://t.co/Y0MPiSktzr
Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides https://t.co/T1ibFbUmGp
All mentions
Microbiome's Role in Mental Health and Neurological Disorders
Neurological disorders contribute to 10 of the total disease burden in India. Mental health issues are prevalent, with a biological component linked to the microbiome ecosystem in our body. Research indicates gut and…
Impact of Salivary Microbiome on Neurological and Mental Health
The microbiome in our mouth influences neurological diseases by sending biochemical signals to the brain, affecting mental health. Research shows oral bacteria produce neuroactive compounds linked to depression and…
A new study reports the bacterial mix of saliva differs in obese and depressed adults. https://t.co/0YW3nPSgvn Obesity and depression are driven by inflammation. Gum disease lifts inflammation by 20%. So managing the oral microbiome with Prevora becomes even more important. https://t.co/Y0MPiSktzr
RT @BMC_series: Suzi Hong and co-authors have published in #BMCMicrobiol a study reporting novel insights into oral microbial-brain connect…
Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides | BMC Microbiology #CMImember #ScientificArticles #JournalArticles https://t.co/B1GZry3a1w
Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides https://t.co/T1ibFbUmGp
Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides https://t.co/2199I3wvII
Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides https://t.co/sTy7OaMLEx
Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides https://t.co/PJXE4qhyAj #medRxiv
M
DK
SP
M
RP
LM
CP